Amgen’s anti-obesity drug reduces weight by up to 20%
Amgen’s experimental drug MariTide helped overweight or obese patients lose up to 20% weight on average, according to a year-long mid-stage trial. The data fell short of investors’ lofty expectations and sent shares down 8% before the market opened on Tuesday.
POPULAR POSTS
The Squid Game series has reached the 330 million viewer mark
December 5, 2024
Amazon is announcing a new list of AI models
December 5, 2024
LIVE STREAM